EUVIMEDEUVIMED entdecken
Vergleichsstudie

Ultrasound‐Guided Hip Injections for Osteoarthritis, Femoroacetabular Impingement Syndrome, and Extra‐articular Pathology With Ketorolac Provide Greater Pain Relief and Similar Duration of Action Compared With Corticosteroids

Kevin Y Chen, Zachary G Brumm, Stephanie E Wong, Nicolas S Hatamiya, Faustine D Ramirez, William A Berrigan, Alan L Zhang iD

Arthroscopy · 2026

DOI: 10.1002/arj.70181 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Arthroscopy, 2026. Verfasst von Kevin Y Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, University of California-San Francisco, San Francisco, California, U.S.A. Hauptthemen laut MEDLINE: Ultrasonography, Interventional, Osteoarthritis, Hip, Femoracetabular Impingement, Ketorolac. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To compare patient outcomes following ultrasound‐guided nonsteroidal anti‐inflammatory drug injections (NSI) versus corticosteroid injections (CSI) for osteoarthritis (OA), femoroacetabular impingement syndrome (FAIS), and extra‐articular tendinopathy (ET) of the hip.

Methods

A retrospective analysis of a single‐institutional database of patients undergoing ultrasound‐guided injections for hip pathology with NSI (ketorolac) and CSI (dexamethasone) between October 2022 and November 2024 was performed. Patients were separated into 3 groups based on hip pathology: OA, FAIS, and ET. Exclusion criteria included avascular necrosis, fracture, inflammatory arthritis, a history of prior hip injections, and patients with less than 6 months of follow‐up or incomplete follow‐up. Outcomes including pre‐injection pain scores, post‐injection pain scores, patient‐reported improvement, effect onset, effect duration, and side effects were analyzed.

Results

Ninety hips from 89 patients were included with minimum 6‐month follow‐up (mean 14.2 ± 6.7 months). No significant demographic differences existed between NSI (n = 45) and CSI (n = 45) groups. FAIS patients were younger than patients with other hip pathologies (42.6 years FAIS, 50.8 ET, 58.8 OA, P < .01). On multivariate analysis, NSI was correlated with a significantly greater decrease in pain score after injection when compared with CSI ( P = .035). There was no difference in pain relief based on hip pathology, but female patients were more likely to show improvement compared with male patients. In patients with reported pain relief from injections, there was no significant difference in overall reported percentage improvement (47% ± 33% NSI, 39% ± 35% CSI, P = .33), duration of effect (93 d ± 124 d NSI, 128 d ± 165 d steroid, P = .35), or effect onset time (3.3 d ± 4.6 d NSI, 11.1 d ± 33.8 d CSI, P = .22).

Conclusions

Ultrasound‐guided injections for hip OA, FAIS, and ET with ketorolac may provide greater pain relief with a similar duration of action compared with corticosteroids. Level of Evidence Level III, therapeutic retrospective comparative matched case series.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ultrasonography, InterventionalOsteoarthritis, HipFemoracetabular ImpingementKetorolacTendinopathyAnti-Inflammatory Agents, Non-SteroidalAdrenal Cortex HormonesDexamethasoneHumansFemaleRetrospective StudiesMaleMiddle AgedInjections, Intra-ArticularAdultTreatment OutcomeAgedPain Measurement

Substanzen

KetorolacAnti-Inflammatory Agents, Non-SteroidalAdrenal Cortex HormonesDexamethasone

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, University of California-San Francisco, San Francisco, California, U.S.A.
  • University of California-San Francisco School of Medicine, San Francisco, California, U.S.A.

ORCID-Profile: Alan L Zhang

Zitieren

APA

Chen, K. Y., Brumm, Z. G., Wong, S. E., Hatamiya, N. S., Ramirez, F. D., Berrigan, W. A., & Zhang, A. L. (2026). Ultrasound‐Guided Hip Injections for Osteoarthritis, Femoroacetabular Impingement Syndrome, and Extra‐articular Pathology With Ketorolac Provide Greater Pain Relief and Similar Duration of Action Compared With Corticosteroids. Arthroscopy. https://doi.org/10.1002/arj.70181

Vancouver

Chen KY, Brumm ZG, Wong SE, Hatamiya NS, Ramirez FD, Berrigan WA, et al. Ultrasound‐Guided Hip Injections for Osteoarthritis, Femoroacetabular Impingement Syndrome, and Extra‐articular Pathology With Ketorolac Provide Greater Pain Relief and Similar Duration of Action Compared With Corticosteroids. Arthroscopy. 2026. doi:10.1002/arj.70181

BibTeX
@article{Chen2026,
  author = {Chen, Kevin Y and Brumm, Zachary G and Wong, Stephanie E and Hatamiya, Nicolas S and Ramirez, Faustine D and Berrigan, William A and Zhang, Alan L},
  title = {Ultrasound‐Guided Hip Injections for Osteoarthritis, Femoroacetabular Impingement Syndrome, and Extra‐articular Pathology With Ketorolac Provide Greater Pain Relief and Similar Duration of Action Compared With Corticosteroids},
  journal = {Arthroscopy},
  year = {2026},
  doi = {10.1002/arj.70181}
}
Kostenlos starten →